Hypotension in dialysed patients;Hypotension artérielle chez le dialysé

Nephrologie

Volumn 22, Issue 3, 2001, Pages 105-113

  Urena R ^a  

^a Clinique de l'Orangerie Aubervilliers   (France)

Author keywords

Adrenomedulline; Blood pressure; Hemodialysis; Nitric oxide; UItrafiltration

Indexed keywords

ADRENOMEDULLIN; ARGININE; NITRIC OXIDE;

AUTONOMIC NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DIALYSIS; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HUMAN; HYPOTENSION; MORTALITY; PATHOPHYSIOLOGY; RETINA VEIN; REVIEW; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; VASCULAR DISEASE; VEIN THROMBOSIS;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; HUMANS; HYPOTENSION; RENAL DIALYSIS; VASODILATOR AGENTS;

EID: 0035006626     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Cardiovascular risk factors in chronic failure and hemodialysis population
2. Accelerated atherosclerosis in prolonged maintenance hemodialysis
3. Cardiovascular disease in patients with chronic renal failure
4. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
5. Peripheral adrenoreceptors in hypotension of hemodialyzed uremic patients
6. Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic renal failure
7. Dialysis-induced hypotension: A fresh look at pathophysiology
8. Hypotension on continuous ambulatory peritoneal dialysis
9. Dialysis hypotension
10. Hemodynamic changes during sequential ultrafiltration and dialysis
11. Intradialytic hypotension: New insights into the mechanisms of vasovagal syncope
12. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension
13. Post-synaptic adrenergic unresponsiveness in hypotensive haemodialysis patients
14. Autonomic nervous system and adrenergic receptors in chronic hypotensive haemodialysis patients
15. Arterial hypotension in chronic hemodialysis patients
16. Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension
17. Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients
18. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension
19. Plasma norepinephrine, epinephrine and dopamine levels in end-stage renal disease
20. Norepinephrine clearance, chromogranin A and dopamine beta-hydroxylase in renal failure
21. Hemodialysis hypotension is not the result of uremic peripheral neuropathy
22. A simple test of cardiac function based upon the heart rate changes induced by the Valsalva maneuver
23. Cardiac denervation in diabetic neuropathy
24. Cardiovascular responses to sustained hand grip in normal subjects and in patients with diabetes mellitus: A test of autonomic function
25. Autonomic dysfunction in hemodialysis patients with persistent hypotension
26. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension
27. Cardiac evaluation in hypotension-prone and hypotension-resistant hemodialysis patients
28. Cardiac function in dialysis patients evaluated by Doppler echocardiography and its relation to intradialytic hypotension: A new index combining systolic and diastolic function
29. Ambulatory blood pressure monitoring in dialysis patients and estimation of mean interdialytique blood pressure
30. On the absorption of fluid from the connective tissue spaces
31. Dialysis hypotension: Do we see light at the end of the tunnel
32. Plasma volume recovery after ultrafiltration in patients with chronic renal failure
33. Blood volume changes and hypotension during hemodialysis
34. Model prediction of plasma volume changes induced by hemodialysis
35. Effect of hemodialysis on left ventricular performance
36. Plasma noradrenaline levels in regular hemodialysis patients
37. Stimulated secretion of arginine vasopressine during hemodialysis in patients with hemodialysis hypotension
38. Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension
39. Role of adenosine in dialysis-induced hypotension
40. Vascular endothelial cells synthesize nitric oxide production from L-arginine
41. Increased nitric oxide production in patients with hypotension during hemodialysis
42. Nitric oxide mediates the cardiovascular instability of haemodialysis patients
43. Role of nitric oxide in hemodialysis hypotension
44. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis
45. Role of nitric oxide in haemodialysis hypotension
46. Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension
47. Enhanced production of nitric oxide by blood-dialysis membrane interaction
48. Endothelium-derived relaxing and contracting factors
49. Role of nitric oxide in hypotension during hemodialysis
50. Inflammation, immunoregulation, and inducible nitric oxide synthase
51. Hemodialysis hypotension: Interaction of inhibitors, iNOS, and the interdialytic period
52. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
53. Nitric oxide and blood pressure in normotensive patients on chronic hemodialysis
54. Indices of activity of the nitric oxide system in hemodialysis patients
55. Nitric oxide and the renal patient
56. Adrenomedullin, a novel hypotensive peptide isolated from human phaemochromocytoma
57. Plasma levels of adrenomedullin, a newly identified hypotensive peptide in patients with hypotension and renal failure
58. Effects of hemodialysis on circulating adrenomedullin concentrations in patients with end-stage renal disease
59. The role of acetate in the etiology of symptomatic induced hypotension
60. On the effects of acetate during hemodialysis
61. Contrasting alterations in pulmonary gas exchange during acetate and bicarbonate dialysis
62. Role of osmolarity in blood pressure stability after dialysis and ultrafiltration
63. Increased ionized calcium and left ventricular contractility during hemodialysis
64. The cause ofinadequate haemodynamic reactions during ultrafiltration
65. Effects of cooler temperature dialysate on hemodynamic stability in « problem » dialysis patients
66. Hemodialysis hypotension: The interleukin hypothesis
67. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis
68. Tolerance of hemodialysis: A randomized cross-over trial of 5h versus 4h treatment time
69. Postprandial blood pressure changes during hemodiatysis
70. Relationship between insulin and hemodialysis-associated hypotension
71. Heparine regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells
72. On the triggering mechanism of vasovagal syncope
73. Fainting precipitated by collapse-firing of venous baroreceptors
74. Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient
75. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients
76. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients
77. « U » curve association of blood pressure and mortality in hemodialysis patients
78. Hypertension/hypotension in dialysis
79. Relationship between blood volume and inferior vena cava diameter during and after hemodialysis
80. Noninvasive monitoring of blood volume during hemodialysis: Its relation with post-dialytic dry weight
81. Measurement of total body water by bioelectrical impedance in chronic renal failure
82. Impact of hemodialysis on dual X-ray absorptiometry bioelectrical impedance measurements, and antropometry
83. Hemodynamic effects of intradialytic food ingestion and the effects of caffeine
84. Significant reduction of the large-vessel blood volume by food intake during hemodialysis
85. Sodium ramping in hemodialysis: A study of beneficial and adverse effects
86. The protective effect of cool dialysate is dependent on patients' predialysis temperature
87. Temperature and vascular stability in hemodialysis
88. Untersuchungen im strömenden blut wacher versuchstiere und des menschen
89. A blood protein monitor for the continuous measurement of blood volume changes during hemodialysis
90. Prevention of haemodynamic risks by continuous blood volume measurement and control
91. A new method of continuous hemoglobinometric measurement of blood volume during hemodialysis
92. A new optical technique for monitoring hematocrit and circulating blood volume: Its application in renal dialysis
93. Reduncing symptoms during hemodialysis by continuously monitoring the hematocrit
94. Mannitol therapy revisited (1940-1997)
95. Dextran deposits in tissues of patients undergoing haemodialysis
96. Dextran hypersensitivity
97. Effect of intravenous fluid on blood pressure course during hemodialysis in hypotensive-prone patients
98. Treatement of dialysis-induced hypotension with L-threo-3,4-dihydroxyphenylserine
99. Leg ulceration during amezinium methyl sulfate therapy for hypotension in a hemodialyzed patient with generalized vascular calcification
100. Antihypotensive and hormonal effects of amezinium methyl sulfate in hypotensive hemodialysis patients
101. Intradialytic dobutamine therapy in maintenance hemodialysis patients with persistent hypotension
102. Effect of sertraline hydrochloride on dialysis hypotension
103. Midodrine: A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders
104. Midodrine efficacy and pharmokinetics in a patient with recurrent intradialytic hypotension
105. Midodrine treatment for patients with hemodialysis hypotension
106. Intradialytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients?
107. Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension
108. Midodrine for the treatment of intradialytic hypotension